FDA — authorised 10 November 2004
- Application: NDA021654
- Marketing authorisation holder: WAYLIS THERAP
- Status: supplemented
🇺🇸 Lovaza in United States
FDA authorised Lovaza on 10 November 2004
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Lovaza approved in United States?
Yes. FDA authorised it on 10 November 2004; FDA has authorised it.
Who is the marketing authorisation holder for Lovaza in United States?
WAYLIS THERAP holds the US marketing authorisation.